GSK Shifts Focus After Haleon Spinoff
With the spinoff of its consumer healthcare operations into the new company Haleon, GSK is turning its focus onto new [...]
Compliance Congress for Specialty Products
Specialty pharmaceutical companies face significant regulatory and industry barriers while attempting to provide therapies for rare, complex, or orphan diseases. [...]
